Fresenius | FRE - Ebit

Aktienkurs
38.95
Täglich Wechseln
0.62 1.62%
Monatlich
-11.54%
Jährlich
-8.40%
Q2 Prognose
39.92




Ebit Veränderung Datum
Akzo Nobel EUR 254M 37M 2026-03
Alcon AG USD 297M 20M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
BASF EUR 1.4B 1.58B 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Beiersdorf EUR 504M 312M 2025-12
DaVita Healthcare Partners USD 473.55M 110.66M 2026-03
Demant DKK 2.07B 201M 2025-12
E.ON EUR 1.06B 349M 2025-12
Essilor EUR 1.38B 626M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 268M 395M 2026-03
Getinge SEK 2.02B 1.2B 2024-12
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GN Store Nord DKK -68M 638M 2026-03
GRIFOLS EUR 249M 103.11M 2026-03
Hikma Pharmaceutical USD 348M 31M 2025-12
Lonza CHF 673M 54M 2025-06
Merck EUR 474M 738M 2025-12
Novartis USD 4.18B 118M 2026-03
Philips EUR 302M 417M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
RWE EUR -139M 716M 2026-03
Sanofi EUR 1.94B 239M 2026-03
Smith & Nephew USD 440M 50M 2025-12